• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities

by | Jun 4, 2024 | Publications

Br J Radiol. 2024 Jun 4:tqae110. doi: 10.1093/bjr/tqae110. Online ahead of print. ABSTRACT OBJECTIVE: To evaluate the provision of imaging at diagnosis of myeloma from the service user perspective with a specific focus on how the experiences of patients align with The...

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

by | Jun 4, 2024 | Publications

N Engl J Med. 2024 Jun 3. doi: 10.1056/NEJMoa2400712. Online ahead of print. ABSTRACT BACKGROUND: Bortezomib, lenalidomide, and dexamethasone (VRd) is a preferred first-line treatment option for patients with newly diagnosed multiple myeloma. Whether the addition of...

Lymphocyte profile in peripheral blood of patients with multiple myeloma

by | Jun 4, 2024 | Publications

Ann Hematol. 2024 Jun 4. doi: 10.1007/s00277-024-05820-x. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a disease which remains incurable. One of the main reasons is a weakened immune system that allows MM cells to survive. Therefore, the current research...

Vitamin D receptor gene polymorphisms and multiple myeloma: a meta-analysis

by | Jun 4, 2024 | Publications

Clin Exp Med. 2024 Jun 4;24(1):118. doi: 10.1007/s10238-024-01382-4. ABSTRACT Vitamin D acts through the vitamin D receptor (VDR), and vitamin D level decreases in multiple myeloma (MM) patients. Single nucleotide polymorphisms in VDR alter its functions to affect the...

Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study

by | Jun 4, 2024 | Publications

Support Care Cancer. 2024 Jun 4;32(7):407. doi: 10.1007/s00520-024-08619-8. ABSTRACT OBJECTIVE: Poor adherence to oral chemotherapy adversely impacts clinical outcomes and escalates overall healthcare costs. Despite barriers to medication adherence, a significant gap...

A new autophagy-related nomogram and mechanism in multiple myeloma

by | Jun 4, 2024 | Publications

Genes Dis. 2023 Sep 21;11(5):101120. doi: 10.1016/j.gendis.2023.101120. eCollection 2024 Sep. NO ABSTRACT PMID:38831978 | PMC:PMC11145194 | DOI:10.1016/j.gendis.2023.101120
« Older Entries
Next Entries »

Recent Content

  • (no title)
  • Caribou’s CB-011 may be effective, safe for hard-to-treat myeloma
  • Therapy wins rare pediatric disease designation for hard-to-treat glioma
  • November shines a spotlight on pancreatic cancer awareness
  • Cero seeking more safety, dosing data on T-cell therapy for AML
  • (no title)
  • Efficacy of novel therapies for refractory and relapsed multiple myeloma in China: A scoping systematic review
  • Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
  • Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT